I read with disappointment the letter by Wai Sin Kung calling for opioid substitution services to be scrapped (
The Pharmaceutical Journal 2017;299:40). The views expressed were unfounded and simplistic. The opioid substitution service does indeed help some users to stop abusing drugs, but it is also there to prevent some of the social upheaval that often follows with a drug addiction, namely, crime, homelessness, prostitution, etc. Many of the service users I see (working within mental health) need supporting and careful management owing to their dual diagnosis (mental health condition and substance misuse) and not locking up in prisons for rehabilitation (at a huge cost to the taxpayer) or ‘outed’ as drug addicts. All this would do would be to drive the addiction underground and bring about the social and economic problems that I have mentioned. I would hope that the views expressed by Kung are that of the minority of our profession.
Anthony Young
Newcastle Upon Tyne
You may also be interested in
What are the views of the RPS and Pharmaceutical Press on AI training using copyrighted materials?

HIV patients should switch to long-acting antiretroviral injectable treatments sooner, study concludes
